Abstract:Introduction: The lower respiratory tract microbiome is widely studied to pinpoint microbial dysbiosis of diversity or abundance that is linked to a number of chronic respiratory illnesses. However, it is vital to clarify how the microbiome, through the release of microbial metabolites, impacts lung health and oncogenesis. Methods: In order to discover the powerful correlations between microbial metabolites and disease, we collected, under electronic bronchoscopy examinations, samples of paired bronchoalveolar lavage fluids (BALFs) from tumor-burden lung segments and ipsilateral non-tumor sites from 28 lung cancer participants, further performing metagenomic sequencing, short-chain fatty acid (SCFA) metabolomics, and multiomics analysis to uncover the potential correlations of the microbiome and SCFAs in lung cancer. Results: In comparison to BALFs from normal lung segments of the same participant, those from lung cancer burden lung segments had slightly decreased microbial diversity in the lower respiratory tract. With 18 differentially prevalent microbial species, including the well-known carcinogens Campylobacter jejuni and Nesseria polysaccharea , the relative species abundance in the lower respiratory tract microbiome did not significantly differ between the two groups. Additionally, a collection of commonly recognized probiotic metabolites called short-chain fatty acids showed little significance in either group independently but revealed a strong predictive value when using an integrated model by machine learning. Multiomics also discovered particular species related to SCFAs, showing a positive correlation with Brachyspira hydrosenteriae and a negative one with Pseudomonas at the genus level, despite limited detection in lower airways. Of note, these distinct microbiota and metabolites corresponded with clinical traits that still required confirmation. Conclusions: Further analysis of metagenome functional capacity revealed that genes encoding environmental information processing and metabolism pathways were enriched in the lower respiratory tract metagenomes of lung cancer patients, further supporting the oncogenesis function of various microbial species by different metabolites. These findings point to a potent relationship between particular components of the integrated microbiota-metabolites network and lung cancer, with implications for screening and diagnosis in clinical settings.

Dissection of Intratumor Microbiome-Host Interactions at Single-Cell Level in Lung Cancer

Spatial meta-transcriptomics reveal intratumor bacterial association with lung cancer cells showing a distinct oncogenic signature.

Host-Microbiome Interaction in Lung Cancer

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

Convergent alteration of lung tissue microbiota and tumor cells in lung cancer

Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

The Pan-Cancer Landscape of Abnormal DNA Methylation and Intratumor Microorganisms.

Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer

Exploring the microbiome: Uncovering the link with lung cancer and implications for diagnosis and treatment

Microbiome Dysbiosis in Lung Cancer: from Composition to Therapy

Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature

Identifications of the potential in-silico biomarkers in lung cancer tissue microbiomes

Interplay Between the Lung Microbiome and Lung Cancer.

Integrative metagenomic, transcriptomic, and proteomic analysis reveal the microbiota-host interplay in early-stage lung adenocarcinoma among non-smokers

The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells

Community Dynamics of Fungi During the Progression of Human Non-Small-Cell Lung Cancer

Deciphering the Immune–Tumor Interplay During Early-Stage Lung Cancer Development via Single-Cell Technology

Host–microbiota Interaction During Cancer Progression from Bulk to Single‐cell Level